ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $973 | +5.1% | 16,756 | -2.6% | 0.00% | 0.0% |
| Q2 2023 | $926 | +47.2% | 17,198 | +8.7% | 0.00% | 0.0% |
| Q1 2023 | $629 | +65.5% | 15,827 | +67.6% | 0.00% | 0.0% |
| Q4 2022 | $380 | -99.9% | 9,446 | -0.4% | 0.00% | – |
| Q3 2022 | $305,000 | +24.5% | 9,483 | +14.8% | 0.00% | – |
| Q2 2022 | $245,000 | +4.7% | 8,260 | -0.6% | 0.00% | – |
| Q1 2022 | $234,000 | -38.7% | 8,310 | +0.3% | 0.00% | – |
| Q4 2021 | $382,000 | +40.4% | 8,282 | -0.2% | 0.00% | – |
| Q3 2021 | $272,000 | -6.2% | 8,302 | +0.3% | 0.00% | – |
| Q2 2021 | $290,000 | -2.0% | 8,275 | +0.9% | 0.00% | – |
| Q1 2021 | $296,000 | +24.4% | 8,200 | 0.0% | 0.00% | – |
| Q4 2020 | $238,000 | +3.0% | 8,200 | 0.0% | 0.00% | – |
| Q3 2020 | $231,000 | -12.8% | 8,200 | 0.0% | 0.00% | – |
| Q2 2020 | $265,000 | -20.7% | 8,200 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $334,000 | -68.8% | 8,200 | -52.7% | 0.00% | 0.0% |
| Q4 2019 | $1,070,000 | -24.5% | 17,346 | -10.8% | 0.00% | -50.0% |
| Q3 2019 | $1,417,000 | -32.3% | 19,446 | -23.6% | 0.00% | -33.3% |
| Q2 2019 | $2,092,000 | +26.3% | 25,452 | +8.3% | 0.00% | +50.0% |
| Q1 2019 | $1,657,000 | +62.0% | 23,494 | +3.4% | 0.00% | +100.0% |
| Q4 2018 | $1,023,000 | -9.9% | 22,714 | +13.1% | 0.00% | 0.0% |
| Q3 2018 | $1,136,000 | -12.1% | 20,085 | +3.9% | 0.00% | -50.0% |
| Q2 2018 | $1,292,000 | +90.8% | 19,338 | +66.3% | 0.00% | +100.0% |
| Q1 2018 | $677,000 | -9.7% | 11,630 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $750,000 | +23.0% | 11,630 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $610,000 | +12.1% | 11,630 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $544,000 | -36.0% | 11,630 | -32.3% | 0.00% | 0.0% |
| Q1 2017 | $850,000 | +37.8% | 17,178 | +68.7% | 0.00% | 0.0% |
| Q4 2016 | $617,000 | -8.6% | 10,180 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $675,000 | +53.1% | 10,180 | +28.9% | 0.00% | 0.0% |
| Q2 2016 | $441,000 | +65.8% | 7,900 | 0.0% | 0.00% | – |
| Q1 2016 | $266,000 | -25.3% | 7,900 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $356,000 | +14.1% | 7,900 | 0.0% | 0.00% | – |
| Q3 2015 | $312,000 | -62.0% | 7,900 | -40.3% | 0.00% | -100.0% |
| Q2 2015 | $821,000 | +32.6% | 13,234 | +33.7% | 0.00% | 0.0% |
| Q1 2015 | $619,000 | – | 9,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |